ZERUN CO., LTD
301636
Jiangsu Hanbon Science and Technology
688755
Longhorn Auto
301488
4
NTGEC
870436
5
Shanghai Zhongzhou Special Alloy Materials
300963
CN Stock MarketDetailed Quotes
301089 Tuoxin Pharmaceutical Group
- 33.90
- +2.42+7.69%
Trading May 16 11:24 CST
4.29BMarket Cap-167.82P/E (TTM)
35.48High31.61Low189.61KlotVolume32.20Open31.48Pre Close636.08MTurnover20.84%Turnover RatioLossP/E (Static)126.54MShares41.0052wk High2.77P/B3.08BFloat Cap23.2052wk Low37.78Limit Up90.98MShs Float229.25Historical High25.18Limit Down12.29%Amplitude23.20Historical Low0.25Dividend TTM33.55Avg Price75.24KlotAsk0.74%Div YieldTTM100Lot Size98.80KlotBid
Tuoxin Pharmaceutical Group Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.46%96.99M | -49.53%421.69M | -56.34%325.75M | -66.70%218.76M | -80.34%108.32M | 6.47%835.51M | 76.42%746.13M | 166.36%656.98M | 325.33%551.01M | 56.17%784.72M |
| Operating revenue | -10.46%96.99M | -49.53%421.69M | -56.34%325.75M | -66.70%218.76M | -80.34%108.32M | 6.47%835.51M | 76.42%746.13M | 166.36%656.98M | 325.33%551.01M | 56.17%784.72M |
| Other operating revenue | ---- | -98.85%40.4K | ---- | --0 | ---- | -48.96%3.53M | ---- | -14.88%4.57M | ---- | 211.47%6.91M |
| Total operating cost | -6.33%104.54M | -14.02%444.66M | -4.64%349.46M | -9.89%230.77M | -23.19%111.6M | 10.64%517.16M | 16.54%366.45M | 26.10%256.09M | 46.58%145.29M | 9.98%467.41M |
| Operating cost | -15.91%67.26M | -15.97%295.75M | 7.24%242.08M | 2.23%165.05M | -15.92%79.99M | 12.45%351.95M | -1.45%225.74M | 9.51%161.45M | 31.34%95.13M | 0.33%313M |
| Operating tax surcharges | 70.66%2.18M | -39.53%7.87M | -53.97%5.19M | -69.36%2.98M | -83.16%1.28M | 10.65%13.02M | 106.30%11.27M | 159.76%9.74M | 390.38%7.58M | 73.40%11.77M |
| Operating expense | 15.27%2.42M | 31.79%12.95M | 5.99%9.52M | 2.73%6.03M | -19.39%2.1M | 9.64%9.83M | 67.92%8.99M | 63.34%5.87M | 32.63%2.61M | 30.63%8.96M |
| Administration expense | 14.34%23.7M | -3.18%91.47M | -25.43%65.79M | -27.50%42.92M | -40.31%20.72M | -10.51%94.47M | 50.28%88.22M | 58.33%59.21M | 90.76%34.72M | 51.13%105.57M |
| Financial expense | 80.96%-138.81K | -1.72%-3.42M | 25.17%-2.03M | -13.55%-2.39M | -253.08%-728.9K | -15.56%-3.36M | 14.74%-2.72M | 13.20%-2.1M | 59.42%-206.44K | -134.06%-2.91M |
| -Interest expense (Financial expense) | 6,472.70%40.78K | -84.12%53.52K | ---- | ---- | -99.78%620.52 | -90.04%337.07K | -88.10%285.06K | -86.60%238.68K | -68.10%285.06K | -62.92%3.38M |
| -Interest Income (Financial expense) | 76.59%-114.07K | 19.84%-2.64M | -134.54%-2.26M | -3.56%-1.82M | 49.53%-487.28K | 34.53%-3.29M | 72.56%-965.43K | 36.21%-1.76M | 41.75%-965.43K | -109.39%-5.02M |
| Research and development | 10.65%9.12M | -21.86%40.05M | -17.26%28.91M | -26.28%16.17M | 50.92%8.25M | 65.22%51.25M | 83.58%34.94M | 64.22%21.93M | -0.49%5.46M | 47.91%31.02M |
| Credit Impairment Loss | -84.36%373.09K | 8.63%-4.1M | 145.00%3.16M | 130.07%2.42M | 127.82%2.39M | -188.41%-4.49M | -239.36%-7.01M | -315.14%-8.04M | -966.55%-8.58M | 322.78%5.07M |
| Asset Impairment Loss | ---- | 0.83%-10.68M | ---- | ---- | ---- | -12.00%-10.77M | -1,249.42%-4.15M | -1,107.76%-3.64M | ---- | -820.89%-9.61M |
| Other net revenue | -33.82%3.81M | -122.41%-747.52K | 647.16%16.56M | 432.69%10.86M | 227.33%5.76M | -72.15%3.34M | -89.06%2.22M | -124.31%-3.27M | -189.04%-4.52M | 587.24%11.98M |
| Fair value change income | 151.27%361.47K | 60.14%875.76K | -193.22%-463.66K | -156.21%-544.78K | -345.84%-705K | 245.84%546.87K | -110.00%-158.13K | -11.75%969.16K | ---158.13K | -74.49%158.13K |
| Invest income | -30.42%1.01M | -89.69%677.32K | -52.88%2.96M | -44.38%1.95M | 5.33%1.45M | 16.97%6.57M | 78.07%6.29M | 52.45%3.51M | 8.74%1.38M | 60,036.24%5.62M |
| -Including: Investment income associates | ---- | -1,775,411.60%-2.05M | ---- | ---- | ---- | -339.15%-115.51 | ---- | ---- | ---- | -99.48%48.3 |
| Asset deal income | ---- | ---5.67K | ---- | ---- | ---4.91K | ---- | ---- | ---- | ---- | --28.07K |
| Other revenue | -21.44%2.07M | 8.79%12.48M | 50.38%10.9M | 78.71%7.03M | -7.12%2.63M | 7.03%11.47M | -25.64%7.25M | -33.60%3.94M | 0.36%2.83M | 141.71%10.72M |
| Operating profit | -250.77%-3.73M | -107.37%-23.72M | -101.87%-7.15M | -100.29%-1.15M | -99.38%2.48M | -2.31%321.68M | 196.64%381.9M | 597.74%397.62M | 1,029.85%401.19M | 315.54%329.29M |
| Add:Non operating Income | -34.03%19.76K | 13,629.99%195.37K | 10,314.26%148.19K | 19,562.18%83.16K | 49,829.20%29.96K | -84.31%1.42K | --1.42K | --422.96 | --60 | 235.80%9.07K |
| Less:Non operating expense | 364.15%253.55K | -18.29%4.21M | 70.72%3.9M | -86.85%267.75K | -96.76%54.63K | 27.81%5.15M | 91.79%2.28M | 135.91%2.04M | 298.61%1.69M | 234.31%4.03M |
| Total profit | -261.82%-3.97M | -108.76%-27.73M | -102.87%-10.9M | -100.34%-1.33M | -99.39%2.45M | -2.69%316.53M | 197.62%379.62M | 604.85%395.58M | 1,038.67%399.5M | 316.79%325.27M |
| Less:Income tax cost | -205.13%-403.53K | -110.68%-7.85M | -112.41%-8.24M | -99.48%446.07K | -99.60%383.82K | 89.65%73.46M | 267.70%66.42M | 4,063.55%86.05M | 1,332.44%95.2M | 214.14%38.73M |
| Net profit | -272.34%-3.56M | -108.18%-19.88M | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M |
| Net profit from continuing operation | -272.34%-3.56M | -108.18%-19.88M | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M |
| Net profit of parent company owners | -272.34%-3.56M | -108.18%-19.88M | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.17%243.07M | 186.06%313.19M | 472.61%309.53M | 970.02%304.31M | 336.05%286.54M |
| Earning per share | ||||||||||
| Basic earning per share | -250.00%-0.03 | -108.29%-0.16 | -100.80%-0.02 | -100.41%-0.01 | -99.17%0.02 | -14.98%1.93 | 186.21%2.49 | 472.09%2.46 | 952.17%2.42 | 243.94%2.27 |
| Diluted earning per share | -250.00%-0.03 | -108.29%-0.16 | -100.80%-0.02 | -100.41%-0.01 | -99.17%0.02 | -14.98%1.93 | 186.21%2.49 | 472.09%2.46 | 952.17%2.42 | 243.94%2.27 |
| Other composite income | 136.17%769.19K | -26.56%-2.13M | 32.79%-1.68M | |||||||
| Other composite income of parent company owners | ---- | 136.17%769.19K | ---- | ---- | ---- | -26.56%-2.13M | ---- | ---- | ---- | 32.79%-1.68M |
| Total composite income | -272.34%-3.56M | -107.93%-19.12M | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.41%240.95M | 186.93%313.19M | 476.15%309.53M | 970.02%304.31M | 350.64%284.86M |
| Total composite income of parent company owners | -272.34%-3.56M | -107.93%-19.12M | -100.85%-2.65M | -100.57%-1.78M | -99.32%2.07M | -15.41%240.95M | 186.93%313.19M | 476.15%309.53M | 970.02%304.31M | 350.64%284.86M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.